Tenderwize
Zurück zur Suche

LP s obsahem pembrolizumabu 2026

Fakultní nemocnice Olomouc·Olomouc - Nová Ulice, Czech Republic·CZK 497.3M | EUR 20.6M·Deadline Jul 16, 2026 · 22 days left·Open·Supplies
High valueStructured notice only
60/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

30 / 100

Risk factors

Eligibility criteria and required documents are not specified in the notice; bidders may be disqualified if they fail t...

Award based solely on lowest price may lead to unsustainable pricing or reduced profit margins.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • CZK 497.3M estimated value
  • Supplies contract
  • 1 lot
  • Duration 36 MONTH
  • Repeated deliveries of medicinal products containing the active substance pembrolizumab.
  • Supply to Fakultní nemocnice Olomouc, Olomouc region, Czech Republic.
Show full summary

Single lot tender for repeated supply of pembrolizumab-containing medicinal products to Fakultní nemocnice Olomouc over 36 months. Estimated value 497,272,797 CZK. Award based solely on lowest price. Open procedure, electronic submission required. Place of performance: Olomouc region, Czech Republic. No selection criteria or required documents specified in the notice.

Risks

Eligibility criteria and required documents are not specified in the notice; bidders may be disqualified if they fail t...

Award based solely on lowest price may lead to unsustainable pricing or reduced profit margins.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Supply of medicinal products with active substance pembrolizumab.
  • Contract duration 36 months.

Administrative

Requirements may be incomplete.

Award Criteria

Lot 1

Zadavatel bude hodnotit v souladu s § 114 odst. 2 ZZVZ ekonomickou výhodnost nabídek podle nejnižší nabídkové ceny v Kč bez DPH, která bude převzata z vyplněného krycího listu nabídkové ceny. V případě rovnosti nejnižších celkových nabídkových cen v Kč bez DPH několika účastníků rozhodne o výběru nejvýhodnější nabídky los. Účastníci, kteří podali shodnou nejnižší celkovou nabídkovou cenu, budou zadavatelem písemně vyzváni k osobní účasti na losování. Hodnotící komise posoudí nabídky podle ust. § 113 ZZVZ (mimořádně nízká nabídková cena)100%

Buyer

Name

Fakultní nemocnice Olomouc

Location

Olomouc - Nová Ulice, CZE

Buyer profile

Open profile

Identifier

00098892

Lots (1)

LOT-0001

LP s obsahem pembrolizumabu 2026

Repeated deliveries of medicinal products containing the active substance pembrolizumab.

SuppliesEU fundedElectronic submissionSME suitable

CZK 497.3M

Estimated value

Location

CZ071, Czech Republic

Duration

36 MONTH

Category

Antineoplastic agents

Selection criteria

Price

Deadline

Deadline Jul 16, 2026

Procurement Details

Publication date
11 Jun 2026
Notice type
Contract notice — standard
Languages
Czech

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
405254-2026
Source notice ID
36d26972-36cc-4b5e-bd5d-e5d1c872ceca

Documents (1)

Similar tenders